← Giovanni Davı̀

Papers by Giovanni Davı̀

Page 2 · newest first

51. Endothelial dysfunction in patients with spontaneous venous thromboembolismHaematologica · 2007
52. Low-Density Lipoprotein-Lowering Medication and Platelet FunctionPathophysiology of Haemostasis and Thrombosis · 2006
53. Association between Circulating Adiponectin and Interleukin-10 Levels in Android Obesity: Effects of Weight LossThe Journal of Clinical Endocrinology & Metabolism · 2005
54. Oxidant stress, inflammation and atherogenesisLupus · 2005
55. Soluble CD40L and Cardiovascular Risk in Asymptomatic Low-Grade Carotid StenosisStroke · 2005
56. CD40-CD40L interactions in platelet activationThrombosis and Haemostasis · 2005
57. Lipid Peroxidation in Diabetes MellitusAntioxidants and Redox Signaling · 2004
58. Helicobacter Pylori Infection Causes Persistent Platelet Activation In Vivo Through Enhanced Lipid PeroxidationArteriosclerosis Thrombosis and Vascular Biology · 2004
59. Oxidant Stress and Platelet Activation in HypercholesterolemiaAntioxidants and Redox Signaling · 2004
60. Soluble CD40 Ligand Plasma Levels in Lung CancerClinical Cancer Research · 2004
61. Association of Inflammation Markers with Impaired Insulin Sensitivity and Coagulative Activation in Obese Healthy WomenThe Journal of Clinical Endocrinology & Metabolism · 2003
62. Enhanced Interleukin-1β in HypercholesterolemiaCirculation · 2003
63. Enhanced Lipid Peroxidation and Platelet Activation in the Early Phase of Type 1 Diabetes MellitusCirculation · 2003
64. Physical exercise increases urinary excretion of lipoxin A₄and related compoundsJournal of Applied Physiology · 2003
65. Platelet Activation, Inflammatory Mediators and HypercholesterolemiaCurrent Vascular Pharmacology · 2003
66. Association between Serum Leptin Levels and 24‐Hour Blood Pressure in Obese WomenObesity Research · 2003
67. Platelet Activation in Obese WomenJAMA · 2002
68. Association Between Enhanced Soluble CD40L and Prothrombotic State in HypercholesterolemiaCirculation · 2002
69. 5‐Lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factorThe FASEB Journal · 2001
70. Oxidative Stress and Platelet Activation in Homozygous HomocystinuriaCirculation · 2001
71. Endothelial Perturbation in Children and Adolescents With Type 1 DiabetesDiabetes Care · 2001
72. Endothelial Perturbation in Cystic FibrosisThrombosis and Haemostasis · 2001
73. In Vivo Lipid Peroxidation and Platelet Activation in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine · 2000
74. Oxidant Stress and Aspirin-Insensitive Thromboxane Biosynthesis in Severe Unstable AnginaCirculation · 2000
75. Effects of Vitamin E Supplementation on F₂-Isoprostane and Thromboxane Biosynthesis in Healthy Cigarette SmokersCirculation · 2000
76. Homocysteine, Coagulation, Platelet Function, and ThrombosisSeminars in Thrombosis and Hemostasis · 2000
77. Morning Sudden Cardiac DeathInternational Journal of Immunopathology and Pharmacology · 2000
78. In Vivo Formation of 8-Iso-Prostaglandin F2αand Platelet Activation in Diabetes MellitusCirculation · 1999
79. Increased Levels of Soluble P-Selectin in Hypercholesterolemic PatientsCirculation · 1998
80. Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients.Diabetes · 1998
81. Enhanced Thromboxane Biosynthesis in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine · 1997
82. In Vivo Formation of 8-Epi-Prostaglandin F2αIs Increased in HypercholesterolemiaArteriosclerosis Thrombosis and Vascular Biology · 1997
83. Diabetes Mellitus, Hypercholesterolemia, and Hypertension but Not Vascular Disease Per Se Are Associated With Persistent Platelet Activation In VivoCirculation · 1997
84. Platelet Activation Markers in Patients with Peripheral Arterial DiseaseThrombosis and Haemostasis · 1997
85. A Comparison of Five Maintenance Therapies for Reflux EsophagitisNew England Journal of Medicine · 1995
86. Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa HypercholesterolemiaArteriosclerosis Thrombosis and Vascular Biology · 1995
87. Demonstration of Rickettsia Conorii-Induced Coagulative and Platelet Activation in vivo in Patients with Mediterranean Spotted FeverThrombosis and Haemostasis · 1995
88. Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism.Journal of Clinical Investigation · 1993
89. Inhibition of thromboxane biosynthesis and platelet function by indobufen in type II diabetes mellitus.Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1993
90. Lp(a) levels in patients undergoing aorto-coronary bypass surgeryEuropean Heart Journal · 1992
91. Increased thromboxane biosynthesis in type IIa hypercholesterolemia.Circulation · 1992
92. Thromboxane Biosynthesis and Platelet Function in Type II Diabetes MellitusNew England Journal of Medicine · 1990
93. Platelet Function During Ticlopidine and Eicosapentaenoic Acid Administration in Patients with Coronary Heart DiseasePlatelets · 1990
94. Clinical pharmacology of platelet cyclooxygenase inhibition.Circulation · 1985
95. Double-Blind, Crossover Study of the Clinical Efficacy and the Hemorheological Effects of Pentoxifylline in Patients With Occlusive Arterial Disease of the Lower LimbsAngiology · 1984
96. The Effect of Two Low Doses of Aspirin on Whole Blood Thromboxane and Prostacyclin Generation in Healthy SubjectsThrombosis and Haemostasis · 1983
97. Platelet Sensitivity to Prostacyclin and Thromboxane Production in Hyperlipidemic PatientsThrombosis and Haemostasis · 1982